CLTCL1 (NM_007098) Human Untagged Clone

CAT#: SC318649

CLTCL1 (untagged)-Human clathrin, heavy chain-like 1 (CLTCL1), transcript variant 1



  "NM_007098" in other vectors (5)

CNY 31,640.00


货期*
4周

规格
    • 10 ug

Product images

经常一起买 (4)
TurboFectin Transfection Reagent (1 mL in 1 vial)
    • 1 ml in 1 vial

CNY 4,090.00


DH5α Chemically Competent Cells (≥10^8 cfu/μg of pUC19 DNA)
    • 5 x 200 ul

CNY 1,280.00


Forward sequencing primer VP1.5, Reverse sequencing primer XL39, 100pmoles each
    • 100 pmol

CNY 480.00


CLTCL1 rabbit polyclonal antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00

Specifications

Product Data
Type Human Untagged Clone
Tag Tag Free
Synonyms CHC22; CLH22; CLTCL; CLTD
Vector pCMV6-Entry
E. coli Selection Kanamycin (25 ug/mL)
Mammalian Cell Selection Neomycin
Sequence Data
>SC318649 representing NM_007098.
Blue=Insert sequence Red=Cloning site Green=Tag(s)

GCTCGTTTAGTGAACCGTCAGAATTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTG
GATCCGGTACCGAGGAGATCTGCCGCCGCGATCGCC
ATGGCGCAGATCCTCCCTGTTCGCTTTCAGGAGCACTTCCAGCTCCAAAACCTTGGAATTAATCCAGCT
AACATTGGATTCAGCACACTGACCATGGAATCTGACAAGTTCATATGTATCCGAGAGAAAGTTGGTGAG
CAGGCACAGGTCACGATCATTGACATGAGTGACCCAATGGCTCCGATCCGACGGCCTATCTCTGCAGAG
AGTGCCATCATGAATCCAGCCTCTAAGGTGATAGCTCTGAAAGCTGGGAAGACACTTCAGATCTTTAAT
ATTGAGATGAAGAGTAAAATGAAGGCTCATACTATGGCAGAAGAAGTGATTTTCTGGAAATGGGTTTCT
GTGAACACTGTTGCCTTGGTGACCGAGACCGCGGTCTACCACTGGAGCATGGAAGGTGACTCCCAGCCC
ATGAAGATGTTTGATAGACATACCAGTCTGGTGGGCTGCCAGGTGATTCACTACCGGACTGATGAGTAC
CAGAAGTGGCTGCTGCTCGTAGGCATCTCGGCTCAGCAAAACCGTGTGGTTGGAGCAATGCAGCTCTAC
TCTGTGGATAGGAAGGTTTCACAACCCATAGAAGGCCATGCTGCGGCTTTTGCAGAGTTCAAGATGGAG
GGGAATGCCAAGCCTGCCACCCTTTTCTGCTTTGCTGTACGTAATCCCACAGGAGGCAAGTTGCACATC
ATTGAAGTTGGACAGCCTGCAGCGGGAAACCAACCTTTTGTAAAGAAAGCAGTAGATGTGTTTTTTCCT
CCAGAGGCACAGAATGATTTTCCAGTGGCTATGCAGATTGGAGCTAAACATGGTGTTATTTACTTGATC
ACAAAGTATGGCTATCTTCATCTGTACGACCTAGAGTCTGGCGTGTGCATCTGCATGAACCGTATTAGT
GCTGACACAATATTTGTCACTGCTCCACACAAACCAACCTCTGGAATTATTGGTGTCAACAAAAAGGGA
CAGGTACTGTCAGTTTGTGTTGAGGAAGATAACATTGTGAATTATGCAACCAACGTGCTTCAGAATCCA
GACCTTGGTCTGCGTTTGGCCGTTCGTAGTAACCTGGCTGGGGCAGAGAAGTTGTTTGTGAGAAAATTC
AATACCCTCTTTGCACAGGGCAGCTATGCTGAAGCCGCCAAAGTTGCAGCGTCTGCACCAAAGGGAATC
CTGCGTACCAGAGAGACGGTCCAGAAATTCCAGAGTATACCCGCTCAGTCTGGCCAGGCTTCTCCATTG
CTGCAGTACTTCGGAATCCTGCTCGACCAGGGTCAGCTCAATAAACTTGAATCCTTAGAACTTTGCCAT
CTGGTTCTTCAGCAGGGGCGTAAGCAACTCCTAGAGAAGTGGCTGAAAGAAGATAAGCTGGAGTGCTCA
GAGGAGCTCGGAGACTTGGTCAAAACCACTGACCCCATGCTCGCTCTGAGTGTGTACCTTCGGGCAAAT
GTGCCAAGCAAAGTGATCCAGTGTTTTGCAGAAACAGGCCAATTCCAGAAAATTGTGCTCTATGCCAAA
AAGGTTGGGTACACCCCAGACTGGATCTTTCTGCTGAGGGGTGTAATGAAGATCAGTCCGGAACAGGGC
CTGCAGTTTTCTCGAATGCTAGTGCAGGACGAGGAGCCGCTGGCCAACATTAGCCAGATTGTGGACATT
TTCATGGAAAACAGTTTAATTCAGCAGTGTACTTCCTTCTTATTGGATGCCTTGAAGAATAATCGCCCA
GCTGAGGGACTCCTGCAGACATGGCTGTTGGAGATGAACCTTGTTCATGCACCCCAGGTTGCAGATGCC
ATCCTTGGAAATAAAATGTTTACTCATTACGACCGGGCCCACATTGCCCAGCTCTGTGAGAAGGCAGGC
CTCCTGCAGCAAGCACTGGAGCACTACACCGACCTCTATGACATCAAGAGGGCTGTGGTCCACACTCAC
CTCCTCAATCCCGAGTGGCTTGTCAATTTCTTTGGCTCCTTATCGGTGGAGGATTCTGTGGAGTGTCTG
CATGCCATGCTGTCTGCTAACATCAGACAGAACCTTCAGCTGTGTGTGCAGGTGGCCTCTAAGTACCAC
GAGCAGCTGGGCACGCAGGCCCTGGTGGAGCTCTTTGAATCCTTCAAGAGTTACAAAGGCCTCTTCTAC
TTCCTGGGCTCAATCGTGAACTTCAGCCAAGACCCAGATGTGCATCTGAAATACATTCAGGCTGCCTGT
AAGACAGGGCAGATCAAGGAGGTGGAGAGGATATGCCGAGAGAGCAGCTGCTACAACCCAGAGCGTGTG
AAGAACTTCCTGAAGGAGGCCAAGCTCACAGACCAGCTTCCCCTCATCATCGTGTGTGATCGTTTTGGC
TTTGTCCATGACCTTGTCCTATATTTATACCGCAACAACCTGCAGAGGTACATTGAGATCTACGTGCAG
AAGGTCAACCCTAGCCGGACCCCAGCTGTGATTGGAGGGCTGCTTGATGTGGATTGTTCTGAGGAAGTG
ATTAAACACTTAATCATGGCAGTGAGAGGACAGTTCTCTACTGATGAGTTGGTGGCTGAAGTAGAAAAA
AGAAATAGGCTCAAGCTGCTGCTTCCCTGGCTGGAGTCCCAGATTCAGGAAGGCTGTGAGGAGCCTGCC
ACTCACAATGCACTGGCTAAAATCTACATCGACAGCAACAACAGCCCCGAGTGCTTCCTGAGAGAGAAT
GCCTACTATGACAGCAGCGTGGTGGGCCGCTACTGTGAGAAGCGAGACCCCCATCTGGCCTGTGTTGCC
TATGAGCGGGGGCAGTGTGACCTTGAGCTCATCAAGGTGTGCAATGAGAATTCTCTGTTCAAAAGCGAG
GCCCGCTACCTGGTATGCAGAAAGGATCCGGAGCTCTGGGCTCACGTCCTTGAGGAGACCAACCCATCC
AGGAGACAGCTAATTGACCAGGTGGTACAGACAGCATTGTCAGAAACACGGGATCCTGAAGAGATTTCG
GTCACTGTCAAAGCCTTTATGACAGCCGACCTGCCTAATGAACTGATTGAACTGCTGGAGAAGATAGTT
CTGGATAACTCTGTCTTCAGCGAGCACAGGAATCTACAGAATCTGTTGATCCTGACTGCCATCAAGGCA
GACCGCACACGGGTCATGGAGTACATCAGCCGCCTGGACAACTATGACGCACTGGACATCGCGAGCATC
GCTGTCAGCAGCGCACTGTATGAGGAGGCCTTCACCGTTTTCCACAAGTTTGATATGAATGCCTCAGCA
ATCCAGGTCCTGATCGAGCACATTGGAAACCTGGACCGGGCATATGAGTTTGCGGAGAGATGCAATGAG
CCTGCTGTGTGGAGTCAGCTGGCCCAAGCCCAGCTCCAGAAAGATTTGGTGAAGGAAGCCATCAACTCC
TATATCAGAGGGGACGACCCTTCCTCTTACCTGGAAGTTGTTCAGTCAGCCAGCAGGAGCAACAACTGG
GAGGATCTAGTTAAATTTCTGCAGATGGCCAGGAAAAAGGGCCGTGAGTCCTATATAGAGACTGAACTT
ATTTTTGCCTTGGCTAAAACCAGCCGTGTTTCTGAGCTAGAAGATTTTATTAATGGACCCAACAATGCC
CACATCCAGCAGGTTGGAGACCGCTGTTACGAGGAGGGAATGTACGAGGCTGCCAAGCTGCTCTATAGC
AATGTTTCTAACTTTGCCCGCCTGGCTTCCACCTTGGTTCACCTCGGTGAGTATCAGGCAGCAGTGGAC
AACAGCCGCAAGGCCAGCAGCACCCGGACGTGGAAGGAGGTGTGCTTTGCCTGCATGGATGGACAAGAG
TTCCGCTTCGCACAGCTGTGTGGTCTTCACATCGTCATTCATGCAGATGAGCTGGAGGAGCTGATGTGC
TATTACCAGGATCGTGGCTACTTTGAGGAGCTGATCTTGCTGTTGGAAGCGGCCCTGGGCCTGGAGCGG
GCCCACATGGGCATGTTCACTGAGCTGGCCATCCTCTACTCCAAATTCAAGCCACAGAAGATGCTGGAG
CATCTGGAGCTTTTCTGGTCCCGTGTCAACATCCCAAAGGTGCTGAGGGCTGCAGAGCAGGCACACCTG
TGGGCTGAGCTGGTGTTCCTCTATGACAAGTACGAGGAGTATGACAATGCTGTGCTCACCATGATGAGC
CACCCCACTGAGGCCTGGAAGGAGGGTCAGTTCAAGGACATCATTACCAAGGTTGCCAACGTCGAGCTC
TGTTACAGAGCCCTGCAGTTCTATTTGGATTACAAACCACTGCTCATCAATGACCTGCTGCTGGTGCTT
TCACCCCGGCTGGACCACACCTGGACAGTCAGTTTCTTTTCAAAGGCAGGTCAGCTGCCCCTGGTGAAG
CCTTACCTGCGGTCAGTCCAGAGCCACAACAACAAGAGTGTGAATGAGGCACTCAACCACCTGCTGACA
GAGGAGGAGGACTATCAGGGCTTAAGGGCATCTATCGATGCCTATGACAACTTTGACAACATCAGCCTG
GCTCAGCAGCTGGAGAAGCATCAGCTGATGGAGTTCAGGTGCATTGCGGCCTATCTGTACAAGGGCAAT
AACTGGTGGGCCCAGAGCGTGGAGCTCTGCAAGAAGGATCATCTCTACAAGGATGCCATGCAGCATGCT
GCAGAGTCGCGGGATGCTGAGCTGGCCCAGAAGTTGCTGCAGTGGTTCCTGGAGGAAGGCAAGAGGGAG
TGCTTCGCAGCTTGTCTCTTCACCTGCTATGACCTGCTTCGCCCAGACATGGTGCTTGAGCTGGCCTGG
AGGCACAACCTCGTGGACTTGGCCATGCCCTACTTCATCCAGGTGATGAGGGAGTACCTGAGCAAGGTG
GACAAACTGGATGCCTTGGAGAGTCTGCGCAAGCAAGAGGAGCATGTGACAGAGCCTGCCCCTCTCGTG
TTTGATTTTGATGGGCATGAATGA

ACGCGTACGCGGCCGCTCGAGCAGAAACTCATCTCAGAAGAGGATCTGGCAGCAAATGATATCCTGGAT
TACAAGGATGACGACGATAAG
GTTTAAACGGCCGGC
Restriction Sites SgfI-MluI     
ACCN NM_007098
Insert Size 4923 bp
OTI Disclaimer Our molecular clone sequence data has been matched to the reference identifier above as a point of reference. Note that the complete sequence of our molecular clones may differ from the sequence published for this corresponding reference, e.g., by representing an alternative RNA splicing form or single nucleotide polymorphism (SNP).
OTI Annotation This TrueClone is provided through our Custom Cloning Process that includes sub-cloning into OriGene's pCMV6 vector and full sequencing to provide a non-variant match to the expected reference without frameshifts, and is delivered as lyophilized plasmid DNA.
Product Components The ORF clone is ion-exchange column purified and shipped in a 2D barcoded Matrix tube containing 10ug of transfection-ready, dried plasmid DNA (reconstitute with 100 ul of water).
Reconstitution 1. Centrifuge at 5,000xg for 5min.
2. Carefully open the tube and add 100ul of sterile water to dissolve the DNA.
3. Close the tube and incubate for 10 minutes at room temperature.
4. Briefly vortex the tube and then do a quick spin (less than 5000xg) to concentrate the liquid at the bottom.
5. Store the suspended plasmid at -20°C. The DNA is stable for at least one year from date of shipping when stored at -20°C.
Reference Data
RefSeq NM_007098.3
RefSeq Size 5542 bp
RefSeq ORF 4923 bp
Locus ID 8218
UniProt ID P53675
Protein Families Druggable Genome
Protein Pathways Endocytosis, Huntington's disease, Lysosome
MW 187 kDa
Gene Summary This gene is a member of the clathrin heavy chain family and encodes a major protein of the polyhedral coat of coated pits and vesicles. Chromosomal aberrations involving this gene are associated with meningioma, DiGeorge syndrome, and velo-cardio-facial syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009]
Transcript Variant: This variant (1) represents the longer transcript and encodes the longer isoform (1).
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Other Versions

Customer Reviews 
Loading...